Login
Search
Search
0 Dates
2025
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
CPC 2025
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Implantable Cardioverter-Defibrillator - do we have alternative predictors to administered shocks?
Session:
SESSÃO DE POSTERS 42 - DISPOSITIVOS CARDÍACOS IMPLANTÁVEIS: CDI E CRT
Speaker:
Lucas Hamann
Congress:
CPC 2025
Topic:
C. Arrhythmias and Device Therapy
Theme:
09. Device Therapy
Subtheme:
09.2 Implantable Cardioverter / Defibrillator
Session Type:
Cartazes
FP Number:
---
Authors:
Lucas Hamann; Joana Massa Pereira; Sofia Andraz; Joana Guerreiro Pereira; Miguel Espirito Santo; Hugo Costa; Pedro de Azevedo; Daniela Silva; Raquel Fernandes; Dina Bento; João Moura Guedes; Jorge Mimoso
Abstract
<p><span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><strong>Introduction:</strong></span></span></span><br /> <span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><span style="color:#000000">Predictors of administered shocks in patients with implantable cardioverter-defibrillators (ICDs) have been studied extensively, with heart failure (HF), a history of chronic obstructive pulmonary disease (COPD), and ventricular tachycardia (VT) at the time of ICD implantation being primary factors. Understanding these predictors remains crucial for improving patient outcomes and quality of life.</span></span></span></p> <p><span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><strong>Objective:</strong></span></span></span><br /> <span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><span style="color:#000000">To identify alternative predictors of administered shocks in ICD patients and evaluate whether these shocks influenced a composite outcome of death, myocardial infarction, stroke, or hospitalization for HF.</span></span></span></p> <p><span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><strong>Methods:</strong></span></span></span><br /> <span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><span style="color:#000000">This retrospective study (2020–2023) analyzed 264 patients with ICDs, stratified into “shocks administered” and “no shocks administered” groups. Categorical variables were reported as frequencies and percentages. Logistic regression was employed for multivariate analysis, with p < 0.05 considered statistically significant.</span></span></span></p> <p><span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><strong>Results:</strong></span></span></span><br /> <span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><span style="color:#000000">The cohort had a mean age of 66 ± 8 years and a mean follow-up period of 29 ± 13 months. Of the participants, 28 (12.5%) experienced administered shocks, while 196 (87.5%) did not. Binary analysis revealed a significantly higher use of antiarrhythmic drugs in the shocks-administered group, but no significant differences were observed for other predictors, including age, gender, hypertension, diabetes mellitus, dyslipidemia, obesity, alcohol use, smoking, left ventricular ejection fraction (LVEF), chronic kidney disease, atrial fibrillation, non-ischemic heart disease, optimized medical therapy, or the etiology of ICD implantation. There was no difference between the two groups regarding the composite outcome (p = 0.550). Multivariate analysis identified obesity as the sole independent predictor of administered shocks (OR: 3.144, p = 0.042).</span></span></span></p> <p><span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><strong>Conclusion:</strong></span></span></span><br /> <span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><span style="color:#000000">This study highlights obesity as a strong independent predictor of administered shocks. These findings underscore the importance of managing established ICD predictors while addressing body weight to improve quality of life and reduce distressing, painful shocks. Given the potential protective properties of obesity against overall mortality, these results prompt further discussion regarding the risk-benefit balance of obesity management in ICD patients.</span></span></span></p> <p> </p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site